NCT05753306 2026-04-08
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
25 trialsNCT01815359 2026-02-05
ICARuS
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT07139951 2025-12-31
HORIZON
Mayo Clinic
Phase 2 Enrolling by invitation
NCT07304258 2025-12-26
A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
Hebei Medical University
Phase 2 Not yet recruiting
NCT04858009 2025-12-16
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Mayo Clinic
Phase 2 Recruiting
NCT07178808 2025-09-17
PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Banner Health
Phase 2 Recruiting
NCT07133490 2025-08-21
INTERACT Stomach-II
Erasmus Medical Center
Phase 2 Not yet recruiting
NCT06427252 2025-07-16
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Active not recruiting
NCT06946901 2025-04-27
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
Shanghai Zhongshan Hospital
Phase 2 Recruiting
NCT06685887 2025-04-11
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Recruiting
NCT02040142 2024-10-24
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Phase 2 Completed
NCT05541146 2023-03-23
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT05497739 2022-08-11
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT02850874 2022-04-27
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT05095467 2021-10-27
HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT04345770 2020-04-14
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Wuhan University
Phase 2 Unknown
NCT02528110 2020-03-24
Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Wuhan University
Phase 2 Completed
NCT03150628 2019-04-17
CISCA
UMC Utrecht
Phase 2 Terminated
NCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT01540344 2018-09-05
COMBATAC
University of Regensburg
Phase 2 Terminated
NCT01580410 2018-07-03
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Wake Forest University Health Sciences
Phase 2 Completed
NCT02779608 2017-01-24
The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites
Fudan University
Phase 2 Unknown
NCT01342653 2016-11-21
HIPEC
Hospital General Universitario Gregorio Marañon
Phase 2 Suspended
NCT02549911 2015-09-15
HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00454519 2009-02-13
IPHC
Wuhan University
Phase 2 Unknown